Speaker & Topic

Dec 6, 2019

Value of Individualized Care.
David Patrick Glynn, MSc, MPharm, PhD(c), Research Fellow in the Team for Economic Evaluation and Health Technology Assessment (TEEHTA) at the University of York.
The recorded lecture will be posted after publication of results.

Nov 29, 2019

Just Coverage Decisions: Including Legal Analysis into the Assessment of Health Technologies
Colleen M. Flood FRSC FCAH, Professor at the University of Ottawa and a University Research Chair in Health Law & Policy. She is the inaugural director of the Ottawa Centre for Health Law Ethics and Policy.

Nov 22, 2019

The Feasibility and Cost of Hepatitis C Elimination - CANCELLED - may be rescheduled for a later date
Jagpreet Chhatwal PhD, Assistant Professor, Harvard Medical School, Senior Scientist, Institute for Technology Assessment, Massachusetts General Hospital and a decision scientist at MGH Institute for Technology Assessment (ITA).

Nov 8, 2019

The impact of patented drug price controls on drug launches: evidence from the OECD countries.
Paul Grootendorst, PhD,, Director of the Division of Social and Administrative Pharmacy in the Leslie Dan Faculty of Pharmacy, University of Toronto; Associate professor in the Faculty of Pharmacy, and the School of Public Policy and Governance, University of Toronto, Toronto, Canada; Adjunct associate professor in the Department of Economics, McMaster University in Hamilton, Canada; Associate editor of Health Economics.

Sept 18, 2019

Transplanting Hepatitis C Virus-Infected versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness Analysis.
Mark H. Eckman, MD, MS, FACP, FACMI, Director - Division of General Internal Medicine, Department of Medicine, University of Cincinnati; Director - Center for Clinical Effectiveness, University of Cincinnati Medical Center; Posey Professor of Clinical Medicine - Department of Medicine, and Professor of Environmental Health , University of Cincinnati.

June 21, 2019

Underestimation of Variance of Predicted Mean Health Utilities Derived from Multi-Attribute Utility Instruments: The Use of Multiple Imputation as a Potential Solution.
Kelvin Kar-Wing Chan, MD, FRCPC, MSc, PhD, medical oncologist at the Sunnybrook Odette Cancer Centre, an associate professor at the University of Toronto, and an associate scientist at the Sunnybrook Research Institute. He specializes in GI oncology and head and neck oncology, Adjunct Scientist, ICES Central, Cancer Research Program, and
Eleanor Pullenayegum, BA, MA, PhD, a Senior Scientist at the Hospital for Sick Children and Associate Professor in the Dala Lana School of Public Health, at the University of Toronto.

June 7, 2019

Development, Assessment and Use of Microsimulation models in Medical Research
Stavroula Chrysanthopoulou, PhD, , an Assistant Professor of Biostatistics, the Department of Biostatistics at Brown University, Providence, Rhode Island, USA.

May 24, 2019

Smartwatch Monitoring of Patients with COPD
Robert Wu, MD, FRCPC, MSc, Clinical Researcher, Toronto General Hospital Research Institute (TGHRI), UHN; Assistant Professor, the Department of Medicine, the University of Toronto.

May 10, 2019

OncoSim – a free cancer simulation tool
Jean Yong, MASc, a consultant for the Canadian Partnership Against Cancer, she is part of the OncoSim team.

April 26, 2019

Innovative Pediatric Clinical Trials: Methodological and logistical challenges
Terry Klassen, MD, MSc, FRCPC, Director of Research for the Manitoba Institute of Child Health (MICH); Associate Dean, Academic, Faculty of Medicine; Director of Research for the Department of Pediatrics and Child Health, University of Manitoba; and Pediatric Emergency Physician, Child Health Program, Winnipeg Health Region; Academic Director, The George & Fay Yee Centre for Healthcare Innovation (CHI); an advisor with

April 26, 2019

Topic 1: Development of a disease history model for Zika virus (ZIKV) infection - A microsimulation model
Raphael Ximenes, PhD, Postdoctoral fellow at Toronto General Hospital Research Institute/ THETA.
Topic 1: State-specific direct medical costs of Hepatitis C in Ontario: A population-level study
Alex Haines, MSc
, Health Economist at THETA Collaborative.

March 22, 2019 

Real-world studies in China: Opportunities and Challenges.
Wendong Chen, MD, PhD, Founder and President of Normin Health, Toronto, Canada and China.

March 8, 2019 

Modeling the Cost Effectiveness of Two Big League Pay-for-Performance Policies.
Ankur Pandya, MPH, PhD, an Assistant Professor of Health Decision Science in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health.

February 22, 2019 

A research smorgasbord: Behavioral, mathematical, and philosophical perspectives on health utility and medical decision-making.
Bart S Ferket, MD, PhD, Department of Population Health Science & Policy, Mt Sinai Hospital, NY.

January 25, 2019 

A research smorgasbord: Behavioral, mathematical, and philosophical perspectives on health utility and medical decision-making.
Barry Dewitt, PhD, the Department of Engineering & Public Policy, Carnegie Mellon University, an MSc in Mathematics and the Foundations of Computer Science from the University of Oxford, and a B. Arts & Sci in mathematics from McMaster University.

January 11, 2019 

User Involvement in Technology Development and Evaluation
Holly Witteman, PhD, an Associate Professor in the Department of Family & Emergency Medicine, Université Laval (Laval University), Quebec City, Canada.